5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 219.11▼ | 218.99▲ | 219.65▼ | 221.15▼ | 237.60▼ |
MA10 | 219.26▼ | 220.59▼ | 221.41▼ | 221.99▼ | 233.01▼ |
MA20 | 220.65▼ | 222.07▼ | 222.65▼ | 237.98▼ | 222.83▼ |
MA50 | 222.38▼ | 221.59▼ | 222.38▼ | 233.34▼ | 218.51▲ |
MA100 | 222.64▼ | 222.66▼ | 232.23▼ | 222.18▼ | 214.68▲ |
MA200 | 220.92▼ | 235.14▼ | 237.04▼ | 215.48▲ | 220.61▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.091▼ | -0.568▼ | -0.529▼ | -2.575▼ | 0.097▲ |
RSI | 36.743▼ | 36.749▼ | 39.734▼ | 39.435▼ | 47.454▼ |
STOCH | 31.490 | 6.769▼ | 7.752▼ | 28.952 | 64.292 |
WILL %R | -81.442▼ | -85.784▼ | -89.117▼ | -84.123▼ | -84.534▼ |
CCI | -51.370 | -84.133 | -119.302▼ | -58.616 | -85.290 |
Wednesday, August 13, 2025 11:02 PM
Alx Oncology Holdings, Inc. (ALXO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Alx Oncology Holdings, Inc. faces a ...
|
Wednesday, August 13, 2025 12:36 AM
ALX Oncology Holdings Inc (ALXO) extends cash runway into 2027, reports significant progress in clinical trials, and outlines strategic focus on targeted oncology approaches.
|
Tuesday, August 12, 2025 01:18 PM
Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in Q4 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 223.61 | 223.82 | 218.65 | 218.70 | 45,548 |
14/08/25 | 224.94 | 225.49 | 221.22 | 223.34 | 58,700 |
13/08/25 | 222.78 | 226.54 | 222.07 | 226.54 | 63,200 |
12/08/25 | 217.16 | 222.60 | 216.06 | 221.29 | 48,200 |
11/08/25 | 218.98 | 219.00 | 210.99 | 215.88 | 56,000 |
08/08/25 | 225.50 | 226.00 | 221.57 | 222.79 | 43,600 |
07/08/25 | 227.07 | 228.55 | 224.30 | 225.00 | 39,900 |
06/08/25 | 224.91 | 228.94 | 223.72 | 226.47 | 71,900 |
05/08/25 | 215.01 | 226.58 | 212.67 | 226.51 | 62,100 |
04/08/25 | 244.48 | 247.16 | 211.74 | 213.41 | 159,200 |
|
|
||||
|
|
||||
|
|